Tumor profiling has opposite effect among more socially advantaged populationsCredit: Joshua Clark/UIC Active surveillance leads to improved quality of life ...
Dana-Farber researchers find patients whose tumors have low aneuploidy levels often have better outcomes following treatment with immune checkpoint inhibitorsCredit: ...
Preclinical research identifies CREB1 as new therapeutic target downstream of frequently mutated genesCredit: MD Anderson Cancer Center HOUSTON - Researchers ...
The Gibson D. Lewis Health Sciences Library works to improve access to authoritative health information for communities in Arkansas, Kansas, ...
Credit: Laboratory of Molecular Immunology at The Rockefeller University Tick-borne encephalitis is a disease just as nasty as it sounds. Once ...
Job site and neighborhood risks should be taken into account when setting priorities, authors argueCredit: Faculty of Medicine & Dentistry, ...
Credit: UTHealth The American Geriatrics Society (AGS) today named Faith Atai, MD, a skilled clinician and medical administrator with a ...
Credit: Frank Curran A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two ...
Credit: Dr. Mold Amsterdam, April 9, 2021 -- This study builds upon two earlier published studies (Mold et al., 2020, ...
Credit: SC4HD The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal ...
The structural revelation could have implications as a therapeutic target in all SARS-CoV-2 variantsCredit: Kelly Lab/Penn State A tiny protein ...
Credit: Copyright: Krenn/CellStemCell/IMBA Researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - demonstrate that ...
How does vaping affect cells, and can it cause DNA damage?Credit: Toxys Imperial Brands scientists have utilised Toxys' ToxTracker suite ...
Credit: Universidad de Sevilla Two studies led by the Mental Health Unit of the Virgen del Rocio University Hospital and ...
